BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26355427)

  • 21. Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation.
    Gambato M; Lens S; Navasa M; Forns X
    J Hepatol; 2014 Nov; 61(1 Suppl):S120-31. PubMed ID: 25443340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus and liver transplantation.
    Ahmed A; Keeffe EB
    Clin Liver Dis; 2001 Nov; 5(4):1073-90. PubMed ID: 11685796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.
    Faisal N; Bilodeau M; Aljudaibi B; Hirsch G; Yoshida EM; Hussaini T; Ghali MP; Congly SE; Ma MM; Leonard J; Cooper C; Peltekian K; Renner EL; Lilly LB
    Transplantation; 2016 May; 100(5):1059-65. PubMed ID: 26950722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C.
    Garcia-Pajares F; Tejedor-Tejada J; Torres-Yuste R; Almohalla-Alvárez C; Sánchez-Ocaña R; Peñas-Herrero I; Cimavilla-Román M; de Benito-Sanz M; Sánchez-Martín F; Sánchez-Antolín G
    Transplant Proc; 2019; 51(1):74-76. PubMed ID: 30655151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Recurrent Hepatitis C Genotype-4 Post-Liver Transplantation with Sofosbuvir plus Simeprevir.
    Ascha M; Ascha M; Zein NN; Alkhouri N; Eghtesad B; Abu-Elmagd K; Diago T; Hanouneh IA
    Int J Organ Transplant Med; 2015; 6(2):86-90. PubMed ID: 26082832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hepatitis C in special populations.
    Suda G; Ogawa K; Morikawa K; Sakamoto N
    J Gastroenterol; 2018 May; 53(5):591-605. PubMed ID: 29299684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus and liver transplantation: where do we stand?
    Burra P; De Martin E; Zanetto A; Senzolo M; Russo FP; Zanus G; Fagiuoli S
    Transpl Int; 2016 Feb; 29(2):135-52. PubMed ID: 26199060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy.
    Campos-Varela I; Moreno A; Morbey A; Guaraldi G; Hasson H; Bhamidimarri KR; Castells L; Grewal P; Baños I; Bellot P; Brainard DM; McHutchison JG; Terrault NA
    Aliment Pharmacol Ther; 2016 Jun; 43(12):1319-29. PubMed ID: 27098374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C management in post-transplant patients.
    Hilgenfeldt E; Firpi RJ
    Minerva Gastroenterol Dietol; 2015 Mar; 61(1):21-9. PubMed ID: 25390286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience.
    Pillai AA; Wedd J; Norvell JP; Parekh S; Cheng N; Young N; Spivey JR; Ford R
    Am J Gastroenterol; 2016 Feb; 111(2):250-60. PubMed ID: 26832650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct acting antiviral therapy after liver transplantation.
    Kwo PY
    Curr Opin Gastroenterol; 2016 May; 32(3):152-8. PubMed ID: 27023161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients.
    Ueda Y; Uemoto S
    Transplantation; 2016 Jan; 100(1):54-60. PubMed ID: 26335914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of liver stiffness measurement, acoustic radiation force impulse measurements, and noninvasive fibrosis markers after direct-acting antivirals for hepatitis C virus G4 recurrence post living donor liver transplantation: Egyptian cohort.
    Alem SA; Said M; Anwar I; Abdellatif Z; Elbaz T; Eletreby R; AbouElKhair M; El-Serafy M; Mogawer S; El-Amir M; El-Shazly M; Hosny A; Yosry A
    J Med Virol; 2018 Sep; 90(9):1508-1515. PubMed ID: 29718546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence.
    Poordad F; Schiff ER; Vierling JM; Landis C; Fontana RJ; Yang R; McPhee F; Hughes EA; Noviello S; Swenson ES
    Hepatology; 2016 May; 63(5):1493-505. PubMed ID: 26754432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients.
    Saab S; Greenberg A; Li E; Bau SN; Durazo F; El-Kabany M; Han S; Busuttil RW
    Liver Int; 2015 Nov; 35(11):2442-7. PubMed ID: 25913321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of histological dynamics, kidney function and diabetes in liver transplant patients after antiviral treatment with direct-acting antivirals: Therapy of HCV-recurrence.
    Teegen EM; Dürr M; Maurer MM; Eurich F; Vollbort A; Globke B; Bahra M; Blaeker H; Pratschke J; Eurich D
    Transpl Infect Dis; 2019 Feb; 21(1):e13020. PubMed ID: 30375710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
    Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
    AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of hepatitis C virus infection with sofosbuvir and simeprevir in the early phase of an allogeneic stem cell transplant.
    Piñana JL; Serra MÁ; Hernández-Boluda JC; Navarro D; Calabuig M; Solano C
    Transpl Infect Dis; 2016 Feb; 18(1):89-92. PubMed ID: 26485423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.